It does not offer oral GLP-1s like Rybelsus , so patients looking for non-injectable options will need to consider other providers, like Shed
Average weight loss : Most users lose between 5% to 15% of their starting weight over a 612-month period
The reasons for the lack of benefit of DPP-4 inhibitors on major cardiovascular outcomes could theoretically be related to the relatively short duration of follow-up in the landmark trials
[5] Leslie SW, Soon-Sutton TL, Sajjad H, Siref LE
Emerging evidence from key clinical trials highlights their multifaceted roles across various physiological systems, including cardiovascular, renal, hepatic, and neurological domains, as shown in Figure 3